CYSLTR1 and prostate cancer: Over-expression of CysLT1R has also been shown in prostate cancer, renal cell carcinoma, transitional cell carcinoma and testicular cancer, and montelukast induces early apoptosis of these cancer cells8, 9, 10, 11, 12, 14.